DURHAM, NC – December 28, 2021 – Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference via webcast on Wednesday, January 12, 2022, at 5:15 p.m. ET.
The live webcast of the presentation, including Q&A, will be available on the Investors section of the Bioventus website and will be archived on that site.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for pain treatment, restorative therapies and surgical solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Media Contact:
Thomas Hill
919-474-6715
[email protected]
Investor Inquiries:
Dave Crawford
919-474-6787
[email protected]
Recent News
Bioventus Amends CartiHeal Acquisition Structure
June 21, 2022
Bioventus Amends CartiHeal Acquisition Structure DURHAM, NC – June 21, 2022 – Bioventus Inc.…
Bioventus Exercises Call Option to Acquire CartiHeal
April 4, 2022
DURHAM, NC – April 4, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global…
Bioventus Receives 501(k) Clearance for StimRouter Pain Management Device
March 1, 2022
Industry Leading Peripheral Nerve Stimulator Upgraded to Improve Patient User Experience with…